Assessment of the influence of test characteristics on the clinical and cost impacts of methicillin-resistant Staphylococcus aureus screening programs in US hospitals.

Infect Control Hosp Epidemiol 2011 Mar;32(3):250-7

Boston Healthcare Associates, Boston, MA 02110-1913, USA.

Objective: To compare the impacts of different methicillin-resistant Staphylococcus aureus (MRSA) screening test options (eg, polymerase chain reaction [PCR], rapid culture) and program characteristics on the clinical outcomes and budget of a typical US hospital.

Methods: We developed an Excel-based decision-analytic model, using published literature to calculate and compare hospital costs and MRSA infection rates for PCR- or culture-based MRSA screening and then used multivariate sensitivity analysis to evaluate key variables. Same-day PCR testing for a representative 370-bed teaching hospital in the United States was assessed in different populations (high-risk patients, intensive care unit [ICU] patients, or all patients) and compared with other test options.

Results: Different screening program populations (all patients, high-risk patients, ICU patients, or patients with previous MRSA colonization or infection only) represented a potential savings of $12,158-$76,624 per month over no program ($188,618). Analysis of multiple test options in high-risk population screening indicated that same-day PCR testing of high-risk patients resulted in fewer infections over 1,720 patient-days (2.9, compared with 3.5 for culture on selective media and 3.8 for culture on nonselective media) and the lowest total cost ($112,012). The costs of other testing approaches ranged from $113,742 to $123,065. Sensitivity analysis revealed that variations in transmission rate, conversion to infection, prevalence increases, and hospital size are important to determine program impact. Among test characteristics, turnaround time is highly influential.

Conclusion: All screening options showed reductions in infection rates and cost impact improvement over no screening program. Among the options, same-day PCR testing for high-risk patients slightly edges out the others in terms of fewest infections and greatest potential cost savings.

Download full-text PDF

Source
https://www.cambridge.org/core/product/identifier/S019594170
Publisher Site
http://dx.doi.org/10.1086/658332DOI Listing
March 2011
4 Reads

Publication Analysis

Top Keywords

high-risk patients
16
same-day pcr
12
pcr testing
12
patients
9
mrsa screening
8
staphylococcus aureus
8
methicillin-resistant staphylococcus
8
test options
8
patients patients
8
impacts methicillin-resistant
8
sensitivity analysis
8
infection rates
8
screening program
8
test characteristics
8
characteristics clinical
8
testing high-risk
8
screening
7
high-risk
5
test
5
program
5

Similar Publications